​

Rein Therapeutics Ownership | Who Owns Rein Therapeutics?

OverviewFinancialsChart

Rein Therapeutics Ownership Summary

Rein Therapeutics is owned by 15.94% institutional investors, 0.08% insiders, and 83.97% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 6.99% of RNTX shares.

RNTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRein Therapeutics15.94%0.08%83.97%
SectorHealthcare Stocks 42.53%10.81%46.67%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bios capital management, lp1.69M6.99%$1.94M
Voss capital1.43M5.93%$2.01M
Vanguard group1.17M4.83%$1.34M
Prosight management, lp567.90K2.35%$650.24K
University of texas/texas am investment managment511.61K2.12%$585.79K
Cable car capital420.00K1.74%$480.90K
Sigma planning253.83K1.05%$290.63K
Geode capital management247.31K1.02%$283.25K
Senvest management230.90K0.95%$264.38K
Gagnon securities228.69K0.95%$261.85K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bios capital management, lp1.69M2.19%$1.94M
Kck22.34K0.34%$52.05K
Cable car capital420.00K0.21%$480.90K
Prosight management, lp567.90K0.15%$650.24K
Voss capital1.43M0.14%$2.01M
University of texas/texas am investment managment511.61K0.08%$585.79K
Gagnon securities228.69K0.05%$261.85K
Senvest management230.90K0.01%$264.38K
Sigma planning253.83K0.01%$290.63K
Kg&l capital management18.00K0.01%$20.61K

Top Buyers

HolderShares% AssetsChange
Vanguard group1.17M-284.30K
Gagnon securities228.69K0.05%156.95K
Prosight management, lp567.90K0.15%139.98K
Renaissance18.30K-18.30K
Xtx topco14.98K0.00%14.98K

Top Sellers

HolderShares% AssetsChange
Sigma planning253.83K0.01%-22.95K
Two sigma securities---16.27K
Ubs group83.00--15.62K
Chicago partners investment group31.05K0.00%-10.19K
Northwestern mutual wealth management42.44K--6.22K

New Positions

HolderShares% AssetsChangeValue
Renaissance18.30K-18.30K$20.95K
Xtx topco14.98K0.00%14.98K$17.16K
Warberg asset management11.00K0.00%11.00K$12.60M
Mercer global advisors inc /adv10.46K-10.46K$11.98K
Rockefeller capital management5.10K-5.10K$5.84K

Sold Out

HolderChange
Citigroup-1.00
Game plan financial advisors-25.00
Jpmorgan chase-32.00
Hexagon capital partners-213.00
Wells fargo & company/mn-1.69K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202519-45.71%3,856,409-42.07%152.10%5-64.29%3-40.00%
Jun 30, 202535-5.41%6,657,20910.63%303,7610.04%14-62.16%5-
Mar 31, 202536-5,995,080-27,636-36---

Recent Insider Transactions

DateNameRoleActivityValue
Nov 14, 2025Voss Capital, LP-Buy$127.59K
Oct 27, 2025Voss Capital, LP-Buy$126.92K
Oct 24, 2025Voss Capital, LP-Buy$41.96K
Oct 28, 2025Voss Capital, LP-Buy$247.96K
Oct 27, 2025Voss Capital, LP-Buy$6.62K

Insider Transactions Trends

DateBuySell
2025 Q44-
2025 Q3--

RNTX Ownership FAQ

Who owns the most shares of Rein Therapeutics?

Rein Therapeutics’s largest shareholders are Bios capital management, lp (1.69M shares, 6.99%), Voss capital (1.43M shares, 5.93%), and Vanguard group (1.17M shares, 4.83%). Together, they hold 17.75% of Rein Therapeutics’s total shares outstanding.

Does Blackrock own Rein Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Rein Therapeutics.

Who is Rein Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Rein Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.19% of its assets in 1.69M Rein Therapeutics shares, valued at 1.94M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools